- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00528138
Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation
Prospective Study Comparing Hyperbilirubinemia, CRP, White Blood Cell Count, and Other Clinical Parameters for the Preoperative Diagnosis of Perforated Acute Appendicitis
It has recently been published that hyperbilirubinemia is a reliable marker for the preoperative diagnosis of perforated acute appendicitis.
The investigators believe, based on their own previous publications, that C-reactive protein (CRP) with or without a white blood cell count and some other clinical parameters, are more specific markers for the preoperative diagnosis of perforated acute appendicitis.
The purpose of this study is to prospectively compare the specificity and sensitivity of hyperbilirubinemia CRP, white blood cell count and other clinical parameters for the preoperative diagnosis of acute appendicitis.
Study Overview
Detailed Description
- Previously validated appendicitis score
- Time from onset of symptoms to diagnosis and to surgery
- Laboratory values: WBC, CRP, liver function test
- SIRS values
- Preoperative and postoperative diagnosis
- Length of hospital stay
- Postoperative complications
- Biopsy results
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
IV Region
-
La Serena, IV Region, Chile, IV Region
- Hospital De La Serena - Emergency Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients scheduled for appendectomies for acute appendicitis at the emergency unit of our institution
- Patients older than 15 years of age to 100 years of age
Exclusion Criteria:
- Appendectomy performed incidentally or for other indications
- Patients younger than 15 years of age
- Alcoholism
- A history of viral hepatitis
- Gilbert's disease
- Dubin Johnson syndrome
- BRIC (benign recurrent intra-hepatic cholestasis) and other documented biliary
- Hemolytic or liver diseases associated with hyperbilirubinaemia
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Simple appendicitis
|
CRP, white blood cell count, hepatic function tests
|
|
2
Perforated appendicitis
|
CRP, white blood cell count, hepatic function tests
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcelo A Beltran, MD, Hospital de La Serena
- Study Director: Rodrigo Barrera, MD, Hospital de La Serena
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HLS-0045-07-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.